ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Iovance Biotherapeutics, Inc. Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$4.31M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.85% | -33.14K shares | -1.02M | $9.58 | 450.87K |
| Q2 2022 | share | Decrease | -4.85% | -24.67K shares | -3.12M | $11.04 | 484.02K |
| Q1 2022 | share | Decrease | -19.21% | -120.91K shares | -3.54M | $16.65 | 508.69K |
| Q4 2021 | share | Increase | +17.89% | 95.52K shares | -1.15M | $19.42 | 629.61K |
| Q3 2021 | share | Decrease | -10.05% | -59.66K shares | -2.27M | $24.66 | 534.08K |
| Q2 2021 | share | Increase | +14.51% | 75.21K shares | -968K | $26.02 | 593.75K |
| Q1 2021 | share | Decrease | -32.08% | -244.88K shares | -19.00M | $31.66 | 518.53K |
| Q4 2020 | share | Decrease | -16.04% | -145.86K shares | 5.48M | $46.4 | 763.42K |
| Q3 2020 | share | Decrease | -5.66% | -54.59K shares | 3.47M | $32.92 | 909.28K |
| Q2 2020 | share | Increase | +5.15% | 47.17K shares | -983K | $27.45 | 963.88K |
| Q1 2020 | share | Increase | +231.71% | 640.34K shares | 19.79M | $29.94 | 916.70K |
| Q4 2019 | share | Increase | 0.00% | 276.36K shares | 7.65M | $27.68 | 276.36K |